Libman-Sacks endocarditis and primary antiphospholipid syndrome

Journal of Heart Valve Disease

Volumn 14, Issue 5, 2005, Pages 700-702

  Gonzalez Juanatey, Carlos ^a   Gonzalez Gay, Miguel A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN G; PREDNISONE;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; ECHOCARDIOGRAPHY; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; LIBMAN SACKS ENDOCARDITIS; LUNG ARTERY PRESSURE; MANDATORY TESTING; MITRAL VALVE REGURGITATION; PATIENT MONITORING; PRIORITY JOURNAL; RISK REDUCTION; SYSTOLIC HEART MURMUR; THORAX RADIOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY;

EID: 27744465492     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996;93:1579-1587
2. Brenner B, Blumenfeld Z, Markiewicz W, Reisner SA. Cardiac involvement in patients with primary antiphospholipid syndrome. J Am Coll Cardiol 1991;18:931-936
3. Schneider C, Bahlmann E, Antz M, et al. Unusual manifestation of Libman-Sacks endocarditis in systemic lupus erythematosus. Circulation 2003;93:202-204
4. Galve E, Ordi J, Barquinero J, Evangelista A, Vilardell M, Soler-Soler J. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med 1992;116:293-298
5. Cervera R, Khamashta A, Font J, et al. High prevalence of significant heart valve lesions in patients with the primary antiphospholipid syndrome. Lupus 1991;1:43-47
6. Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 1993;125:1123-1129
7. Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus: Association with raised anticardiolipin antibodies. Circulation 1990;82:369-375
8. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-997
9. Herreros-Guilarte B, Golpe-Gomez R, Berrazueta JR. Regression of lupus endocarditis after treatment of an arteriovenous fistula. Int J Cardiol 1996;55:199-203